Silence Therapeutics Plc (SLN)
13.30
-0.25
(-1.85%)
USD |
NASDAQ |
Sep 10, 16:00
13.30
0.00 (0.00%)
After-Hours: 18:56
Silence Therapeutics Max Drawdown (5Y) : 92.31% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 92.31% |
| July 31, 2026 | 92.31% |
| June 30, 2026 | 92.31% |
| May 31, 2026 | 92.31% |
| April 30, 2026 | 92.31% |
| March 31, 2026 | 92.31% |
| February 28, 2026 | 92.31% |
| January 31, 2026 | 92.31% |
| December 31, 2025 | 92.31% |
| November 30, 2025 | 92.31% |
| October 31, 2025 | 92.31% |
| September 30, 2025 | 92.31% |
| August 31, 2025 | 92.31% |
| July 31, 2025 | 92.31% |
| June 30, 2025 | 92.31% |
| May 31, 2025 | 92.31% |
| April 30, 2025 | 92.31% |
| March 31, 2025 | 90.05% |
| February 28, 2025 | 85.50% |
| January 31, 2025 | 83.74% |
| December 31, 2024 | 83.74% |
| November 30, 2024 | 83.74% |
| October 31, 2024 | 83.74% |
| September 30, 2024 | 83.74% |
| August 31, 2024 | 83.74% |
| Date | Value |
|---|---|
| July 31, 2024 | 83.74% |
| June 30, 2024 | 83.74% |
| May 31, 2024 | 83.74% |
| April 30, 2024 | 83.74% |
| March 31, 2024 | 83.74% |
| February 29, 2024 | 83.74% |
| January 31, 2024 | 83.74% |
| December 31, 2023 | 83.74% |
| November 30, 2023 | 83.74% |
| October 31, 2023 | 83.74% |
| September 30, 2023 | 83.74% |
| August 31, 2023 | 83.74% |
| July 31, 2023 | 83.74% |
| June 30, 2023 | 83.74% |
| May 31, 2023 | 83.74% |
| April 30, 2023 | 83.74% |
| March 31, 2023 | 78.13% |
| February 28, 2023 | 71.82% |
| January 31, 2023 | 71.82% |
| December 31, 2022 | 71.82% |
| November 30, 2022 | 71.82% |
| October 31, 2022 | 71.82% |
| September 30, 2022 | 71.82% |
| August 31, 2022 | 71.82% |
| July 31, 2022 | 71.82% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Biodexa Pharmaceuticals Plc | 100.0% |
| Mereo BioPharma Group Plc | 95.13% |
| NuCana Plc | 99.99% |
| Autolus Therapeutics Plc | 96.58% |
| Compass Pathways Plc | 96.03% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -27.00 |
| Beta (5Y) | 1.448 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 87.32% |
| Historical Sharpe Ratio (5Y) | -0.1588 |
| Historical Sortino (5Y) | -0.3034 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.90% |